Stock Scorecard

Stock Summary for Sunshine Biopharma Inc (SBFM) - $1.55 as of 6/14/2025 9:39:10 AM EST

Total Score

16 out of 30

Safety Score

30 out of 100

Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for SBFM

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for SBFM

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for SBFM

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for SBFM

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for SBFM (30 out of 100)

Stock Price Rating (Max of 10) 2
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 10
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 3
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for SBFM

Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug - Sunshine Biopharma ( NASDAQ:SBFM ) 4/2/2025 3:35:00 PM
US Stock Futures Slip Ahead Of 'Liberation Day' Tariffs Announcement: Expert Points To Uncertainty Amid Higher Risk Premia - Antelope Ent Hldgs ( NASDAQ:AEHL ) , Advanced Micro Devices ( NASDAQ:AMD ) 4/2/2025 9:54:00 AM
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth - AbbVie ( NYSE:ABBV ) , BioNTech ( NASDAQ:BNTX ) 9/4/2024 1:15:00 PM
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031 - Inovio Pharmaceuticals ( NASDAQ:INO ) , Moderna ( NASDAQ:MRNA ) 9/4/2024 12:30:00 PM
Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket - KKR ( NYSE:KKR ) 6/10/2024 9:59:00 AM
Why Riot Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - AgriFORCE Growing Systems ( NASDAQ:AGRI ) 4/22/2024 9:23:00 AM
NORA PHARMA RECEIVES HEALTH CANADA APPROVAL FOR NIOPEG®, A BIOSIMILAR OF NEULASTA® 4/19/2024 3:15:00 PM
Dow Surges Over 100 Points; Netflix Shares Slide After Q1 Results - AGBA Group Holding ( NASDAQ:AGBA ) , Next e GO ( NASDAQ:EGOX ) 4/19/2024 1:55:00 PM
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session 4/17/2024 5:54:00 PM
Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings - Abbott Laboratories ( NYSE:ABT ) , Edible Garden AG ( NASDAQ:EDBL ) 4/17/2024 2:07:00 PM

Financial Details for SBFM

Company Overview
Ticker SBFM
Company Name Sunshine Biopharma Inc
Country USA
Description Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the development of anticancer drugs. The company is headquartered in Pointe-Claire, Canada.
Sector Name TRADE & SERVICES
Industry Name SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Most Recent Quarter 3/31/2025
Next Earnings Date N/A

Stock Price History
Last Day Price 1.55
Price 4 Years Ago 116.90
Last Day Price Updated 6/14/2025 9:39:10 AM EST
Last Day Volume 69,483
Average Daily Volume 113,800
52-Week High 9.36
52-Week Low 1.17
Last Price to 52 Week Low 32.48%

Valuation Measures
Trailing PE N/A
Industry PE 63.30
Sector PE 48.44
5-Year Average PE 11.60
Free Cash Flow Ratio 0.73
Industry Free Cash Flow Ratio 39.00
Sector Free Cash Flow Ratio 60.13
Current Ratio Most Recent Quarter 4.11
Total Cash Per Share 2.13
Book Value Per Share Most Recent Quarter 8.38
Price to Book Ratio 0.31
Industry Price to Book Ratio 5.96
Sector Price to Book Ratio 10.89
Price to Sales Ratio Twelve Trailing Months 0.20
Industry Price to Sales Ratio Twelve Trailing Months 2.54
Sector Price to Sales Ratio Twelve Trailing Months 2.22
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics
Total Shares Outstanding 4,555,900
Market Capitalization 7,061,645
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -13.94%
Reported EPS 12 Trailing Months -5.76
Reported EPS Past Year -0.84
Reported EPS Prior Year -12.88
Net Income Twelve Trailing Months -5,030,212
Net Income Past Year -5,134,000
Net Income Prior Year -4,506,000
Quarterly Revenue Growth YOY 18.00%
5-Year Revenue Growth 340.11%
Operating Margin Twelve Trailing Months -14.60%

Balance Sheet
Total Cash Most Recent Quarter 9,686,529
Total Cash Past Year 9,686,529
Total Cash Prior Year 16,292,347
Net Cash Position Most Recent Quarter 9,686,529
Net Cash Position Past Year 9,686,529
Long Term Debt Past Year 0
Long Term Debt Prior Year 1,900,000
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 23,500,754
Total Stockholder Equity Prior Year 21,207,361
Total Stockholder Equity Most Recent Quarter 23,500,754

Free Cash Flow
Free Cash Flow Twelve Trailing Months -14,721,133
Free Cash Flow Per Share Twelve Trailing Months -3.23
Free Cash Flow Past Year -14,852,027
Free Cash Flow Prior Year -9,563,210

Options
Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 0.04
MACD Signal 0.01
20-Day Bollinger Lower Band 0.85
20-Day Bollinger Middle Band 1.85
20-Day Bollinger Upper Band 2.85
Beta 0.96
RSI 53.25
50-Day SMA 693.63
150-Day SMA 0.00
200-Day SMA 1,135.15

System
Modified 6/14/2025 9:39:12 AM EST